$LFMD News

LifeMD: What The Bulls Got Wrong

LifeMD, Inc. 2026 Q2 - Results - Earnings Call Presentation

HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8

LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript

BTIG Maintains Buy on LifeMD, Lowers Price Target to $9

LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss

LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est

LifeMD Sees Q3 Sales $48.000M-$51.000M vs $58.547M Est

LifeMD Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $47.300M Miss $49.152M Estimate

LifeMD To Launch Program For XYOSTED Injection

LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand

HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. Q1 2026 Earnings Call Summary

LifeMD Q1 Earnings Call Highlights

LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide

LifeMD (LFMD) Q1 2026 Earnings Transcript

LifeMD Reports First Quarter 2026 Results